People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Indapta Therapeutics Inc. | — | Pharma | Series C | $84.4M | $289.9M | 2022 |
Laura Stoppel at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Laura Stoppel on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ronald Martell | 1 | 4 |
| Mark Frohlich | 1 | 3 |
| Lori Hu | 1 | 3 |
| GUY DIPIERRO | 1 | 2 |
| Fabio Pucci | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.